Subscribe

248 - Biogen

- Jay Fram
Jay Fram

The biotechnology company discovers and manufactures treatments for autoimmune disorders, neurodegenerative diseases and hemophilia.

More from FORTUNE

Key Metrics & Financials (Last Fiscal Year)

Revenues ($M)$11449
Revenue Percent Change6.4%
Profits ($M)$3,702.8
Profits Percent Change4.4%
Assets ($M)$22877
Market Value — as of March 31, 2017 ($M)$59,046
Employees7,400
Previous Rank263

Company Facts

Employees7,400
SectorHealth Care
IndustryPharmaceuticals
HQ LocationCambridge, MA
CEOMichel Vounatsos
CEO Title-
Websitewww.biogen.com
Years on Fortune 500 List8

See Full List

Outbrain

More from FORTUNE